Radiopharm Theranostics (ASX:RAD) - developing a portfolio of assets targeting cancer
18 May 2022 - Radiopharm Theranostics Limited (ASX:RAD) CEO and Managing Director Riccardo Canevari provides an update on the company's pipeline and discusses the recent licensing of an asset from UCLA.